Literature DB >> 19474709

Fixed drug eruption: pathogenesis and diagnostic tests.

Tetsuo Shiohara1.   

Abstract

PURPOSE OF REVIEW: Fixed drug eruption is a simplified disease model for elucidating the mechanism(s) of how skin inflammation is induced by skin-resident T cells. In this review, we focus on how the presence of intraepidermal CD8+T cells resident in the fixed drug eruption lesions can provide exciting new clues to our understanding of pathomechanisms of inflammatory skin diseases. RECENT
FINDINGS: Intraepidermal CD8+T cells with an effector-memory phenotype resident in fixed drug eruption lesions have a major contributing role in the development of localized tissue damage. Activation of these CD8+T cells is sufficient for triggering the lesion, however, but not sufficient to cause extensive tissue damage observed in the fully evolved lesions; additional recruitment of CD4+ and CD8+T cells to a specific tissue site would also contribute to the late stage of lesion development. The influx of regulatory T cells into the epidermis observed in fully evolved lesions would serve to limit harmful immune reactions. Consistent with this, positive patch test reactions are only observed at the site of previous lesions harboring significant numbers of intraepidermal CD8+T cells.
SUMMARY: Intraepidermal CD8+T cells may represent double-edged swords of the skin immune system with protective and destructive capacity.

Entities:  

Mesh:

Year:  2009        PMID: 19474709     DOI: 10.1097/ACI.0b013e32832cda4c

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  41 in total

Review 1.  The emerging role of resident memory T cells in protective immunity and inflammatory disease.

Authors:  Chang Ook Park; Thomas S Kupper
Journal:  Nat Med       Date:  2015-06-29       Impact factor: 53.440

2.  Soluble peptide treatment reverses CD8 T-cell-induced disease in a mouse model of spontaneous tissue-selective autoimmunity.

Authors:  So Yeon Paek; Fumi Miyagawa; Hong Zhang; Jay T Linton; Shelley B Hoover; R Mark Simpson; Stephen I Katz
Journal:  J Invest Dermatol       Date:  2011-11-17       Impact factor: 8.551

Review 3.  Memory T cells as an occupying force.

Authors:  Michael J Bevan
Journal:  Eur J Immunol       Date:  2011-05       Impact factor: 5.532

Review 4.  Overview of penicillin allergy.

Authors:  Christopher Chang; Mubashar M Mahmood; Suzanne S Teuber; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

5.  Mucosal fixed drug eruption in a patient treated with ornidazole.

Authors:  Charu Mohan Marya; Gaurav Sharma; Vijay P Parashar; Vandana Dahiya
Journal:  J Dermatol Case Rep       Date:  2012-03-27

Review 6.  A case of entecavir-associated bullous fixed drug eruption and a review of literature.

Authors:  Selami Aykut Temiz; İlkay Özer; Arzu Ataseven; Sıddıka Fındık
Journal:  Turk J Gastroenterol       Date:  2019-03       Impact factor: 1.852

7.  Testing for drug hypersensitivity syndromes.

Authors:  Craig M Rive; Jack Bourke; Elizabeth J Phillips
Journal:  Clin Biochem Rev       Date:  2013-02

8.  Fluconazole-induced Fixed Drug Eruption.

Authors:  Cory Allen Gaiser; Dominick Sabatino
Journal:  J Clin Aesthet Dermatol       Date:  2013-03

9.  Ciprofloxacin-induced generalised non-bullous fixed drug eruption.

Authors:  Mohamed Iliyas; Mudda Ram Subba Reddy; Uma Devi
Journal:  BMJ Case Rep       Date:  2018-06-04

Review 10.  Cutaneous drug reactions in children: an update.

Authors:  Kara Heelan; Neil H Shear
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.